StockVS

Keen Vision Acquisition Corporation (KVACW) Analyse boursière

Keen Vision Acquisition Corporation

$0.06

+$0.05 (+455.45%)

Dernière mise à jour : 26 mai 2026

Historique des Prix

Analyse

Présentation de l'entreprise

Keen Vision Acquisition Corporation, identified by the ticker symbol KVACW, operates as a special purpose acquisition company (SPAC) that does not currently possess significant operational assets or revenue-generating activities. The corporate entity is structured with the explicit intention to consummate a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or a similar business combination with one or more target businesses or entities in the future. The company's sector and industry classifications are listed as unavailable, which is consistent with the operational status of many SPACs prior to their target company identification and merger completion. Regarding its scale, the available financial data indicates a Price to Book ratio of -0.05, while market capitalization, annual revenue, and employee count are reported as unavailable metrics. This absence of traditional scale indicators such as market cap and revenue suggests that the company is in a pre-transaction phase where its valuation is not yet established by historical earnings or sales, but rather by the potential value of the prospective business combination it seeks to execute.

Santé financière

The reported Net Income for the trailing twelve months stands at $1.91 million, a figure that appears anomalous given the company's lack of significant operations and zero revenue. This gap between negligible revenue and positive net income reveals a complex cost structure typical of SPACs, where non-operating income such as interest on cash balances or specific accounting adjustments may drive profitability before the merger transaction occurs. Free Cash Flow is reported as unavailable, reflecting the absence of operational cash flows from a revenue-generating business, which inherently limits the company's financial flexibility until a target acquisition is finalized. An analysis of the three primary margins—Gross Margin, Operating Margin, and Profit Margin—shows a value of 0.0% for each, indicating that the company generates no gross profit from sales and no operating income from its core business activities. The balance sheet presents a cash position of $11,206 against total debt of $3.98 million, creating a scenario where liabilities exceed liquid assets. Although the Debt to Equity ratio is listed as unavailable due to the lack of equity data, the negative Price to Book ratio of -0.05 further underscores the asset-light and potentially distressed nature of the balance sheet prior to any merger. The Current Ratio is recorded at 0.01, a metric that indicates severe short-term liquidity constraints, suggesting the company holds significantly fewer current assets relative to its current liabilities. Return on Equity and Return on Assets are both unavailable, metrics which typically reveal management effectiveness but are not applicable in the current absence of significant equity or asset bases.

Évaluation de la valorisation

The trailing P/E ratio and forward P/E ratio are both unavailable, implying that standard earnings-based valuation models cannot be applied to this entity at this time. The Price to Book ratio is explicitly stated as -0.05, a figure that indicates the market values the company at a fraction of its book value, or in this specific accounting context, suggests a negative equity position relative to the share price. The Price to Sales ratio and EV/EBITDA are also unavailable, meaning that alternative valuation metrics reliant on sales multiples or enterprise value multiples cannot be calculated to assess the company's relative standing. The 52-week high and 52-week low for the stock are both recorded at $0.04, indicating that the trading range has remained flat within a single price point over the last year. Consequently, the current price sits at the absolute floor of its 52-week range, showing no price appreciation relative to the recent high or low. The Beta value is reported as -0.05, a highly unusual metric that suggests the stock's price volatility has moved inversely to the broader market or is statistically neutralized in a way that defies standard market correlation models.

Growth & Income

The Revenue Growth year-over-year and Earnings Growth year-over-year figures are both unavailable for the standard period, though the Earnings Growth is specifically noted as -25.3% in the available data points, indicating a decline in profitability. This specific earnings contraction, when juxtaposed with the lack of revenue data, implies that the company's financial performance is deteriorating or that the available earnings figure of $1.91 million is a one-time event subject to sharp declines. As the company does not pay a dividend, the Dividend Yield and Payout Ratio are unavailable, confirming that the entity reinvests any available earnings or utilizes its cash reserves to fund its search for a merger target rather than distributing returns to shareholders. The overall growth and income profile is characterized by a complete absence of traditional growth metrics and dividend income, relying entirely on the potential value creation from a future business combination to alter its financial trajectory.

Cette analyse est générée par IA à titre informatif uniquement et ne constitue pas un conseil financier. Les données peuvent être retardées ou inexactes. Faites toujours vos propres recherches et consultez un conseiller financier qualifié avant de prendre des décisions d'investissement.

À propos de Keen Vision Acquisition Corporation

Keen Vision Acquisition Corporation does not have significant operations. The company intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, and related business combinations with one or more businesses or entities. It also intends to focus on businesses in the biotechnology, consumer goods, and agriculture sectors. The company was formerly known as Central Acquisition Limited and changed its name to Keen Vision Acquisition Corporation in September 2021. Keen Vision Acquisition Corporation was incorporated in 2021 and is based in Summit, New Jersey.

La description de l'entreprise est affichée en anglais.

Visiter le site →

Statistiques Clés

Capitalisation
N/A
Ratio P/E
N/A
Plus Haut 52 Sem.
$0.01
Plus Bas 52 Sem.
$0.01
Bêta
-0.04

Données fournies par Yahoo Finance via yfinance. Mis à jour quotidiennement.

Info Entreprise

Bourse
NASDAQ
Pays
United States